Parallax Volatility Advisers’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-45,900
Closed -$269K 2513
2023
Q4
$269K Buy
45,900
+45,441
+9,900% +$538K ﹤0.01% 1723
2023
Q3
$11.6K Hold
459
﹤0.01% 2105
2023
Q2
$63.8K Hold
459
﹤0.01% 2053
2023
Q1
$41.8K Hold
459
﹤0.01% 2237
2022
Q4
$62.9K Sell
459
-4,568
-91% -$1.55M ﹤0.01% 2340
2022
Q3
$4.36M Buy
5,027
+3,977
+379% +$2.49M 0.01% 1077
2022
Q2
$460K Hold
1,050
﹤0.01% 1937
2022
Q1
$458K Sell
1,050
-4,516
-81% -$2.85M ﹤0.01% 1937
2021
Q4
$4.96M Buy
5,566
+390
+8% +$410K ﹤0.01% 1206
2021
Q3
$6.56M Buy
+5,176
New +$6.27M 0.01% 1124
2021
Q2
Sell
-600
Closed -$795K 3693
2021
Q1
$795K Buy
+600
New +$850K ﹤0.01% 2184

Other funds holding CANO

Parallax Volatility Advisers's CANO Position: Q4 2023 in Review

Parallax Volatility Advisers sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 167 shares — an estimated $1.98K sold.

Parallax Volatility Advisers first reported a position in CANO in Q2 2021 and held it in 5 quarters. The position peaked at $285K in Q2 2021. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

  • Parallax Volatility Advisers reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
  • Parallax Volatility Advisers sold 167 Cano Health, Inc. shares in Q4 2023, an estimated $1.98K.
  • Parallax Volatility Advisers first reported a position in Cano Health, Inc. in Q2 2021 and held it in 5 quarters.
  • Parallax Volatility Advisers's Cano Health, Inc. position peaked at $285K in Q2 2021.
  • 50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on Parallax Volatility Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.